Sweden -
English -
Läkemedelsverket (Medical Products Agency)
levodopa/karbidopa/entakapon doc 125 mg/31,25 mg/200 mg filmdragerad tablett
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
levodopa/karbidopa/entakapon doc 175 mg/43,75 mg/200 mg filmdragerad tablett
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
levodopa/karbidopa/entakapon doc 100 mg/25 mg/200 mg filmdragerad tablett
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
levodopa/karbidopa/entakapon doc 75 mg/18,75 mg/200 mg filmdragerad tablett
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
levodopa/karbidopa/entakapon doc 150 mg/37,5 mg/200 mg filmdragerad tablett
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
levodopa/karbidopa/entakapon doc 50 mg/12,5 mg/200 mg filmdragerad tablett
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
levodopa/karbidopa/entakapon doc 200 mg/50 mg/200 mg filmdragerad tablett
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml intestinal gel
European Union -
English -
EMA (European Medicines Agency)
rasagiline mylan
mylan s.a.s. - rasagiline tartrate - parkinson disease - anti-parkinson drugs - rasagiline mylan is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
Ireland -
English -
HPRA (Health Products Regulatory Authority)
levodopa/carbidopa/entacapone teva 50/12.5/200 milligram film coated tablet
teva pharma b.v. - levodopa, carbidopa, entacapone - film coated tablet - 50/12.5/200 milligram - dopa and dopa derivatives dopa and dopa derivatives